Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04002726
Other study ID # 2019-KEP-284 - 1
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 8, 2019
Est. completion date July 12, 2019

Study information

Verified date May 2022
Source London School of Hygiene and Tropical Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trachomatous inflammation-follicular (TF) is diagnosed by looking for clinical signs of infection of everted eyelids (conjunctivae) of children. The overall objective of this project is to investigate the effectiveness, acceptability and feasibility of an app-based versus slide-based IGA for trachoma graders. Fieldwork will take place during routine Tropical Data trainings. A non-inferiority randomised controlled trial design will be employed, with grader trainees randomised to app- or slide-based training, and then to app- or slide-based IGA testing. The training and IGA testing method will be compared with field IGA test score to determine which method best predicts passing the field IGA test.


Description:

Trachoma graders are currently trained using either slide- or app-based testing systems. The investigators want to formally assess whether the app-based training and testing system leads to better field-based diagnosis than the slide-based training and testing system. The investigators will also ask participants for their views on acceptability of the two systems and conduct a cost-consequences analysis of the two systems. Objectives and approach: 1.1 To compare the two classroom IGA tests (app-based and slides-based) in terms of their ability to predict trainee success in the field IGA test. 1.2 To assess whether the kappa score threshold for the classroom IGA tests is appropriate. 1.3 To conduct a cost-consequences analysis of the training systems in order to effectively target the use of an app-based assessment and training system. 1.4 To investigate whether grader trainee characteristics have an impact on trainee performance in the IGA tests. 1.5 To obtain feedback on the app-based system's usability and acceptability. 1.6 To compare the two classroom IGA training methods (app-based and slides-based) in terms of classroom IGA test (app-based and slides-based) outcome and field IGA test outcome.


Recruitment information / eligibility

Status Terminated
Enrollment 32
Est. completion date July 12, 2019
Est. primary completion date July 12, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All trainers and trainee graders who attend selected Tropical Data training events will be eligible for inclusion in the study. Exclusion Criteria: - Individuals who do not provide consent are not eligible for inclusion in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Inter-grader agreement (IGA) app
A smartphone-based app with images of conjunctivae for trachoma grading training purposes.

Locations

Country Name City State
Tanzania Arusha region Arusha

Sponsors (9)

Lead Sponsor Collaborator
London School of Hygiene and Tropical Medicine Federal Minstry of Health of Ethiopia, Jos University Teaching Hospital, National Institute for Medical Research, Tanzania, Pan American Health Organization, RTI International, Sightsavers, University College London Hospitals, World Health Organization

Country where clinical trial is conducted

Tanzania, 

Outcome

Type Measure Description Time frame Safety issue
Primary Classroom IGA success The proportion of participants successfully passing (kappa =0.7) the app-based IGA. 1 day
Primary Classroom IGA success The proportion of participants successfully passing (kappa =0.7) the slide-based IGA. 1 day
Primary Field IGA success The correlation between classroom IGA score and field IGA score 3 days
Primary Field IGA success The proportion of participants who successfully pass the classroom IGA test (kappa =0.7) who also successfully pass the field-based IGA test (kappa =0.7) 3 days
Secondary Trainee characteristics Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing classroom IGA test 5 days
Secondary Trainee characteristics Association (reported as proportions, unadjusted and adjusted odds ratios) between trainee characteristics and the probability of successfully passing the field IGA test 5 days
Secondary Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based training. Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based training. 45 minutes
Secondary Acceptability and feasibility (common themes from focus group discussions) of app versus slide-based IGA testing. Common themes, as determined through thematic analysis of focus group discussion transcripts, relating to acceptability and feasibility of app versus slide-based IGA testing. 45 minutes
Secondary Cost of app versus slide-based training Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based training 5 days
Secondary Cost of app versus slide-based IGA testing Cost (overall and broken down by category: personnel; supplies; transit; telecommunications) of app versus slide-based IGA testing 5 days
See also
  Status Clinical Trial Phase
Completed NCT03676140 - Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) Phase 3
Completed NCT01949454 - Fluorometholone as Ancillary Therapy for TT Surgery N/A
Completed NCT01202331 - Tripartite International Research for the Elimination of Trachoma Phase 4
Completed NCT05634759 - Enhancing the A in SAFE for Trachoma Phase 4
Recruiting NCT04185402 - Azithromycin Reduction to Reach Elimination of Trachoma Phase 4
Active, not recruiting NCT00886015 - Modified Instrumentation for Surgery to Correct Trichiasis Phase 3
Completed NCT00792922 - Partnership for Rapid Elimination of Trachoma Phase 4
Completed NCT00522860 - A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery Phase 4
Completed NCT00221364 - Trachoma Elimination Follow-up Phase 4
Completed NCT00322972 - Trachoma Amelioration in Northern Amhara (TANA) Phase 4
Withdrawn NCT00286026 - Azithromycin in Control of Trachoma II Phase 4
Completed NCT00347763 - Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania Phase 4
Terminated NCT03997487 - Smartphone App for Taking Images of Conjunctivae N/A
Not yet recruiting NCT06289647 - Azithromycin Reduction to Reach Elimination of Trachoma B Phase 4
Withdrawn NCT02655432 - Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population Phase 0
Completed NCT01767506 - A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial N/A
Completed NCT00618449 - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Phase 4
Completed NCT00356720 - Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma Phase 3
Completed NCT03813069 - Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma Phase 2
Recruiting NCT03335072 - Kebele Elimination of Trachoma for Ocular Health Phase 4